There is a clear-sightedness not only that a low-intensity chronic inflammation co-exists, but also that it precedes the development of T2DM; one example is the presence of markers that have predictive capacity in relation to T2DM, such as PCR and IL-6. This evidence concerns the gene IL6 and type 2 diabetes mellitus.